About
Aseptuva develops medical technology to prevent hospital-acquired infections, specifically targeting bacterial colonization and biofilm formation on catheter entry sites to reduce sepsis and bloodstream infections in intensive care patients.
Explore Aseptuva's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.